Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update Lilia Andrade-Ortega; Daniel Xibillé-Friedmann; Dionicio A. Galarza-Delgado; Miguel Ángel Saavedra; José Alvarez-Nemegyei; Mary-Carmen Amigo-Castañeda; Hilda Fragoso-Loyo; María Vanessa Gordillo-Huerta; Fedra Irazoque-Palazuelos; Luis Javier Jara-Quezada¿; Javier Merayo-Chalico; Margarita Portela-Hernández; Sandra Sicsik-Ayala; Carlos Abud-Mendoza; Deshire Alpizar-Rodriguez; José Luis Amaya-Estrada; Yaneth R. Barragán-Navarro; Sandra M. Carrillo-Vázquez; Zully Castro-Colín; Luis Javier Cruz-Álvarez; Sergio Durán-Barragán; Jorge A. Esquivel-Valerio; Jorge Iván Gamez-Nava; Conrado García-García; Laura Gonzalez-Lopez; Jaime Hadid-Smeke; Alina Hernández-Bedolla; María Fernanda Hernández-Cabrera; David A. Herrera-VanOostdam; Gabriel Horta-Baas; Alberto E. Iturbide-Escamilla; Sandra Muñoz-Lopez; Cesar Pacheco-Tena; Mario Pérez-Cristóbal; Rafael R. Pimentel-Leon; Mercedes Pinto-Ortiz; María Azucena Ramos-Sánchez; Diana V. Sandoval-Cabrera; Karina Santana de Anda; Luis H. Silveira; Leonor A. Barile-Fabris;

Effectiveness and safety of rituximab in systemic lupus erythematosus: A case series describing the experience of 2 centres Vicenç Juan Gómez; Irene Carrión-Barberá; Tarek Carlos Salman Monte; Asunción Acosta; Vicenç Torrente-Segarra; Jordi Monfort;

Controversy about the use and financing of SYSADOA for osteoarthritis in Spain: An analysis of the scientific-social debate in the media Pedro Alfonso Domínguez Vera; Luis Carrasco Páez;